We are live on ! Find out more
WAM

Warberg Asset Management Portfolio holdings

AUM $600M
1-Year Est. Return 23.37%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+23.37%
3 Year Est. Return
+49.78%
5 Year Est. Return
+106.43%
10 Year Est. Return
AUM
$697M
AUM Growth
+$169M
Cap. Flow
-$172M
Cap. Flow %
-24.71%
Top 10 Hldgs %
65.88%
Holding
269
New
37
Increased
38
Reduced
43
Closed
54
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOBBW
101
Mobilicom Ltd Warrants
MOBBW
$2.4B
$28.6K ﹤0.01%
89,375
-2,725
-3% -$729
EONR.WS
102
EON Resources Warrants
EONR.WS
$1.46M
$28.1K ﹤0.01%
+201,105
New +$18.3K
ESPR
103
CALL
DELISTED
Esperion Therapeutics
ESPR
$26.8K ﹤0.01%
10,000
-10,000
-50% -$24.3K
NEOVW icon
104
NeoVolta Inc Warrant
NEOVW
$1.12M
$26.7K ﹤0.01%
165,332
-33,279
-17% -$7.28K
DPRO
105
Draganfly
DPRO
$162M
$26.5K ﹤0.01%
+5,583
New +$42.2K
FGNX
106
FG Nexus Inc
FGNX
$44.2M
$26.4K ﹤0.01%
153
-14
-8% -$2.41K
APCXW
107
DELISTED
AppTech Payments Corp Warrant
APCXW
$23K ﹤0.01%
69,609
+102
+0.1% +$51
DFSCW
108
DEFSEC Technologies Warrant
DFSCW
$21.5K ﹤0.01%
182,888
-8,541
-4% -$807
PETVW
109
DELISTED
PetVivo Holdings, Inc. Warrant
PETVW
$20.4K ﹤0.01%
204,183
-4,903
-2% -$786
AXDX
110
DELISTED
Accelerate Diagnostics
AXDX
$19.8K ﹤0.01%
+20,000
New +$31.6K
FGIWW
111
FGI Industries Warrant
FGIWW
$300K
$19.1K ﹤0.01%
121,152
BEATW icon
112
Heartbeam Inc Warrant
BEATW
$59.1K
$19K ﹤0.01%
76,045
+18,700
+33% +$5.12K
FRSX
113
Foresight Autonomous Holdings
FRSX
$3.84M
$18.2K ﹤0.01%
810
+251
+45% +$5.6K
NRSNW icon
114
NeuroSense Therapeutics Warrant
NRSNW
$3.71M
$17.4K ﹤0.01%
41,406
-22,096
-35% -$5.56K
FREEW
115
DELISTED
Whole Earth Brands, Inc. Warrant
FREEW
$17.1K ﹤0.01%
312,649
+151,907
+95% +$10.1K
CREVW
116
DELISTED
Carbon Revolution PLC Warrant
CREVW
$15.5K ﹤0.01%
175,300
-14,700
-8% -$950
SVREW
117
SaverOne 2014 Ltd Warrant
SVREW
$15.5K ﹤0.01%
183,181
-2,300
-1% -$217
SGE
118
DELISTED
Strong Global Entertainment, Inc.
SGE
$15.3K ﹤0.01%
10,399
-1,300
-11% -$1.68K
APLMW icon
119
Apollomics Inc Warrant
APLMW
$1.44M
$15.3K ﹤0.01%
511,000
+65,400
+15% +$1.98K
SNGX icon
120
Soligenix
SNGX
$5.59M
$14.7K ﹤0.01%
1,531
+281
+22% +$3.16K
BIAFW icon
121
bioAffinity Technologies
BIAFW
$112K
$12K ﹤0.01%
15,679
-7,247
-32% -$2.41K
BTBDW icon
122
BT Brands Warrant
BTBDW
$143K
$11.5K ﹤0.01%
118,082
-16,877
-13% -$2.04K
WLDSW icon
123
Wearable Devices Ltd Warrant
WLDSW
$9.38K ﹤0.01%
163
VBIV
124
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$9.04K ﹤0.01%
15,000
RBOT.WS
125
DELISTED
Vicarious Surgical Inc Warrants
RBOT.WS
$8.72K ﹤0.01%
112,000

Similar funds

Warberg Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Warberg Asset Management held 269 positions worth $697M, up 32% from $528M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Warberg Asset Management withdrew a net $172M in Q1 2024, closing 54 positions and reducing 43 holdings. Its most notable exit was Invesco Ultra Short Duration ETF, an estimated $1.37M position sold in full.

By sector, the portfolio is most concentrated in Financials at 1.7% of assets, down from 2.5% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Warberg Asset Management opened a new position in Stereotaxis worth $1.74M.

  • Warberg Asset Management's largest Q1 2024 buy was Stereotaxis: 665,688 shares worth $1.74M.
  • Warberg Asset Management added most to Expand Energy Corp Class B Warrants in Q1 2024, an estimated $863K increase.
  • Warberg Asset Management's biggest Q1 2024 reduction was Hertz Global Holdings Warrants, cutting an estimated $1.11M.
  • Warberg Asset Management fully exited Invesco Ultra Short Duration ETF in Q1 2024, selling an estimated $1.37M.
  • Warberg Asset Management's ten largest holdings make up 66% of its $697M portfolio in Q1 2024.
  • Warberg Asset Management opened 37 new positions and closed 54 in Q1 2024.
  • Warberg Asset Management's portfolio value rose 32% quarter-over-quarter to $697M.

Based on Warberg Asset Management's 13F filing for Q1 2024, filed 6 May 2024.